WJPPS Citation

Login

Search

News & Updation

  • Updated Version
  • WJPPS introducing updated version of OSTS (online submission and tracking system), which have dedicated control panel for both author and reviewer. Using this control panel author can submit manuscript
  • Call for Paper
    • WJPPS  Invited to submit your valuable manuscripts for Coming Issue.
  • Journal web site support Internet Explorer, Google Chrome, Mozilla Firefox, Opera, Saffari for easy download of article without any trouble.
  •  
  • New Impact Factor
  • WJPPS Impact Factor has been Increased to 8.025 for Year 2024.

  • WJPPS: MARCH ISSUE PUBLISHED
  • March Issue has been successfully launched on 1 March 2024.

  • ICV
  • WJPPS Rank with Index Copernicus Value 84.65 due to high reputation at International Level

  • Scope Indexed
  • WJPPS is indexed in Scope Database based on the recommendation of the Content Selection Committee (CSC).

Abstract

BIO-EQUIVALENCE STUDY OF TWO INJECTABLE IVERMECTIN-CLOSANTEL FORMULATIONS (CLOSAMECTIN® AND CLOSAMECPLEX®) IN CALVES

Ashraf Elkomy* and Mohamed Aboubakr

ABSTRACT

The present study was designed to assess the comparative bio-equivalence of Closamectin® and Closamecplex® in healthy calves after SC injection of both products in a dose of (200 μg ivermectin and 5 mg closantel/kg b.wt). Ten calves were divided into two groups (each contains 5 calves). The first group was designed to study the pharmacokinetics of Closamectin ®, while the 2nd group was designed to study the pharmacokinetics of Closamecplex®. Each calf in both groups was Sc injected with (200 μg ivermectin and 5 mg closantel/kg b.wt). Blood samples were obtained from the jugular vein and collected immediately before and at, 1, 4, 8, 12, 24, 48, 72, 96, 120, 144, 168 and 192 hours after a single SC injection. The disposition kinetics of ivermectin in Closamectin® and Closamecplex® revealed that, the maximum blood concentrations [Cmax] were 48.66 and 47.44 μg/ml and attained at [tmax] of 32.07 and 31.89 hours, respectively. The disposition kinetics of closantel in Closamectin® and Closamecplex® revealed that, the maximum blood concentrations [Cmax] were 66.48 and 63.49 μg/ml and attained at [tmax] of 42.86 and 42.23 hours, respectively. In conclusion: Closamecplex® is bioequivalent to Closamectin® since the ratios of Cmax, AUC0-192 and AUC0-∞ (T/R) for ivermectin were 0.97, 0.96 and 0.95 respectively and the ratios of Cmax, AUC0-192 and AUC0-∞ (T/R) for closantel were 0.95, 0.94 and 0.94 respectively. These are within the Bio-equivalence acceptance range. Closamectin® and Closamecplex® are therefore bioequivalent and interchangeable in calves.

Keywords: .


[Download Article]     [Download Certifiate]

Call for Paper

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Online Submission

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More

Email & SMS Alert

World Journal of Pharmacy and Pharmaceutical Sciences (WJPPS)
Read More